Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: INSTITUTO GRIFOLS S.A.
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Approved | 02467526 | INSTITUTO GRIFOLS S.A. | FLEBOGAMMA 10% | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 100 MG / ML |
Approved | 02467488 | INSTITUTO GRIFOLS S.A. | FLEBOGAMMA 5% | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 50 MG / ML |
Approved | 02263661 | INSTITUTO GRIFOLS S.A. | HUMAN ALBUMIN GRIFOLS 20% | Human | No | Schedule D | 1 | ALBUMIN (HUMAN) | 20 % |
Marketed | 02514222 | INSTITUTO GRIFOLS S.A. | VISTASEAL | Human | Yes | Schedule D | 2 | FIBRINOGEN (HUMAN) | 80 MG / 1 ML |
Marketed | 02514230 | INSTITUTO GRIFOLS S.A. | VISTASEAL | Human | Yes | Schedule D | 2 | FIBRINOGEN (HUMAN) | 160 MG / 2 ML |
Approved | 02514249 | INSTITUTO GRIFOLS S.A. | VISTASEAL | Human | Yes | Schedule D | 2 | FIBRINOGEN (HUMAN) | 240 MG / 3 ML |
Marketed | 02514257 | INSTITUTO GRIFOLS S.A. | VISTASEAL | Human | Yes | Schedule D | 2 | FIBRINOGEN (HUMAN) | 400 MG / 5 ML |
Application information
Related information
Contact us
Version 4.0.3